Global Head, Vice President, Commercial Hemophilia and Complement, Rare Blood Disorders @ Sanofi
Head, VP US and Global Commercial Strategic Marketing, Hematology, Complement Inline and Pipeline @ Bioverativ, a Sanofi company
SVP, Head, Global Marketing and Launch Excellence @ Shire
Vice President, Global Inhibitors and Hemophilia B, Hematology @ Baxalta
Vice President, Global Hemophilia Marketing, Inhibitors and Hemophilia B Portfolio @ Baxter International Inc.
Senior Director Portfolio and LCM Management, Hematology @ Bayer
Executive Director, Global Brand Team Head-Parkinsons @ Bayer
Mel Hayes's Education
Columbia University - Columbia Business School
MBA (General Managment, Finance, Marketing)
2001 - 2003
Mel Hayes's Skills
Strategy
Management
Pharmaceutical Industry
Pharmaceutical Sales
Oncology
Product Launch
Market Access
Cardiology
Managed Care
Neurology
Mel Hayes's Summary
Mel Hayes, based in Boston, MA, US, is currently a Chief Operating Officer at Fulcrum Therapeutics, bringing experience from previous roles at Fulcrum Therapeutics, HKH Consulting LLC., Sanofi Genzyme and Bioverativ, a Sanofi company. Mel Hayes holds a 2001 - 2003 MBA in General Managment, Finance, Marketing @ Columbia University - Columbia Business School. With a robust skill set that includes Strategy, Management, Pharmaceutical Industry, Pharmaceutical Sales, Oncology and more, Mel Hayes contributes valuable insights to the industry. Mel Hayes has 2 emails and 1 mobile phone number on RocketReach.